Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity
- PMID: 9066101
Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity
Abstract
Antineutrophil cytoplasmic antibodies (ANCA) are a group of autoantibodies first associated with Wegener's granulomatosis (WG). In autoimmune liver diseases, ANCA have been described recently in patients with primary biliary cirrhosis (PBC), autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC). Controversy exists about the prevalence and specificity of ANCA in patients with autoimmune liver diseases. The purpose of this study was first to assess the prevalence of antineutrophil antibodies in patients with primary biliary cirrhosis and second to identify possible target antigens of antineutrophil antibodies. Sera from 33 patients with PBC, 75 patients with AIH, 16 patients with PSC, 90 control sera (chronic hepatitis B, chronic hepatitis C, alcoholic liver cirrhosis, systemic lupus erythematosus) and sera from healthy blood donors were enrolled in the present study. ANA and ANCA were detected using standard protocols, antibodies against the nuclear antigen SP100 were detected by ELISA with recombinant antigen, antibodies against neutrophil alpha-granules were detected by ELISA. P-ANCA were found in two of 33 PBC sera, both patients presented with PBC/AIH overlap syndrome. In six of 33 (18%) PBC sera a nuclear dot like immunofluorescence pattern (antineutrophil nuclear antibodies, ANNA) was observed. These dots were small in size and located all over the nucleus, the anti-SP100 fluorescence. This result was confirmed by IFT on HEp-2 cells and by ELISA. High tier antibodies against SP100 were found to be specific for patients with PBC. Comparing the IFT results on HEp-2 cells and human neutrophils, we found an excellent correlation (Spearman's rank correlation coefficient = 0.968, P < 0.001). ANCA were detected in AIH type-1 (75%), SLA-positive AIH (36%) and PSC (63%). AIH type-2 was found to be ANCA negative. All PSC contained no antibodies against neutrophil alpha-granules. Our results show: 1. P-ANCA in patients with PBC indicate a PBC/AIH overlap syndrome; 2. ANNA in patients with PBC are mostly directed against SP100; 3. neutrophil granule components are not the ANCA specific antigens in patients with PSC.
Similar articles
-
Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.Eur J Med Res. 2004 Sep 29;9(9):439-48. Eur J Med Res. 2004. PMID: 15546809
-
Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C.Fukushima J Med Sci. 1998 Dec;44(2):83-92. Fukushima J Med Sci. 1998. PMID: 10091380
-
PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis.Am J Gastroenterol. 2010 Jan;105(1):125-31. doi: 10.1038/ajg.2009.596. Epub 2009 Oct 27. Am J Gastroenterol. 2010. PMID: 19861957
-
[Autoimmune hepatitis and overlap syndrome: diagnosis].Praxis (Bern 1994). 2002 Aug 21;91(34):1339-46. doi: 10.1024/0369-8394.91.34.1339. Praxis (Bern 1994). 2002. PMID: 12233264 Review. German.
-
[Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis].Gastroenterol Hepatol. 1999 Jan;22(1):11-3. Gastroenterol Hepatol. 1999. PMID: 10089705 Review. Spanish.
Cited by
-
ANCA-Associated Vasculitis: An Update.J Clin Med. 2021 Apr 1;10(7):1446. doi: 10.3390/jcm10071446. J Clin Med. 2021. PMID: 33916214 Free PMC article. Review.
-
Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases.Clin Rev Allergy Immunol. 2005 Apr;28(2):115-33. doi: 10.1385/CRIAI:28:2:115. Clin Rev Allergy Immunol. 2005. PMID: 15879618 Review.
-
Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis.Clin Exp Immunol. 1998 Jun;112(3):507-15. doi: 10.1046/j.1365-2249.1998.00583.x. Clin Exp Immunol. 1998. PMID: 9649223 Free PMC article.
-
Autoantibodies as prognostic markers in autoimmune liver disease.Dig Dis Sci. 2010 Aug;55(8):2144-61. doi: 10.1007/s10620-010-1268-4. Epub 2010 May 13. Dig Dis Sci. 2010. PMID: 20464491 Review.
MeSH terms
Substances
LinkOut - more resources
Medical